SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001610717-24-000197
Filing Date
2024-03-29
Accepted
2024-03-29 16:57:27
Documents
2
Period of Report
2024-03-21

Document Format Files

Seq Description Document Type Size
1 form3.html 3  
1 form3.xml 3 5253
2 linpoa.htm EX-24 8254
  Complete submission text file 0001610717-24-000197.txt   14916
Mailing Address 700 SAGINAW DR REDWOOD CITY CA 94063
Business Address 700 SAGINAW DR REDWOOD CITY CA 94063 415-766-3638
Revolution Medicines, Inc. (Issuer) CIK: 0001628171 (see all company filings)

IRS No.: 472029180 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O ERASCA, INC. 10835 ROAD TO THE CURE, SUITE 140 SAN DIEGO CA 92121
Business Address
Wei Lin (Reporting) CIK: 0001872772 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39219 | Film No.: 24804642